Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Prestige Brands rolls out FiberChoice, BC Powder brand extensions; subsidiary cross-selling aids Atrium Innovations; Dr. Reddy’s downplays switch outlook; Nu Skin gears up for ageLOC weight management launch; more Sales & Earnings In Brief.
You may also be interested in...
The private labeler sees about $115 billion worth of branded Rx products with potential to switch OTC, including statins and longer-shot switches for diabetes, hypertension and topical steroid drugs. Perrigo’s shorter-term pipeline includes equivalents of proton pump inhibitors Nexium, Protonix and Aciphex.
The company says it successfully integrated the OTC portfolio acquired from GlaxoSmithKline and is using free cash flow to trim its debt load in the wake of the debt-financed $660 million deal. Prestige reported Q1 net sales up 54.7%, including 4.2% organic growth in OTC health care.
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.